BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 10616201)

  • 1. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
    Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
    Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
    Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-independent nephrotoxic serum nephritis in Munich Wistar rats. Immunologic and ultrastructural studies.
    Pilia PA; Boackle RJ; Swain RP; Ainsworth SK
    Lab Invest; 1983 May; 48(5):585-97. PubMed ID: 6341711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
    Fujigaki Y; Batsford S; Yamashita F; Yonemura K; Hishida A; Kawachi H; Shimizu F; Vogt A
    Virchows Arch; 2001 Feb; 438(2):136-45. PubMed ID: 11253115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental glomerulonephritis in the guinea pig. II. Ultrastructural lesions of the basement membrane associated with proteinuria.
    Couser WG; Spargo BH; Stilmant MM; Lewis EJ
    Lab Invest; 1975 Jan; 32(1):46-55. PubMed ID: 1089838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy.
    Minto AW; Kalluri R; Togawa M; Bergijk EC; Killen PD; Salant DJ
    Proc Assoc Am Physicians; 1998; 110(3):207-17. PubMed ID: 9625527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural change of the glomerular basement membrane in rats with Heymann nephritis revealed by ultrahigh resolution scanning electron microscopy.
    Hironaka K; Makino H; Onbe T; Yamasaki Y; Shikata K; Kamata K; Ota Z
    J Pathol; 1996 May; 179(1):112-20. PubMed ID: 8691335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
    Bertani T; Remuzzi G; Poggi A; Delaini F; Sacchi G; Morassi L; Verroust P; Mecca G; Donati MB
    Clin Exp Immunol; 1983 Jan; 51(1):38-44. PubMed ID: 6339125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term evolution of immune deposits in passive Heymann nephritis.
    Soares VA; Almeida DB
    Braz J Med Biol Res; 1992; 25(2):149-59. PubMed ID: 1339511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M; Gross ML; Amann K; Ritz E
    J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats.
    Macconi D; Ghilardi M; Bonassi ME; Mohamed EI; Abbate M; Colombi F; Remuzzi G; Remuzzi A
    J Am Soc Nephrol; 2000 Mar; 11(3):477-489. PubMed ID: 10703671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine lupus nephritis. A structure-function study.
    Kiberd BA
    Lab Invest; 1991 Jul; 65(1):51-60. PubMed ID: 2072665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat.
    Adler S; Baker P; Pritzl P; Couser WG
    J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A change in glomerular permeability in renovascular hypertension. Participation of angiotensin and structural lesions].
    Franco M; Tapia E; Gabbai F; Cermeño JL; Calleja C; Pérez JM; Barrios R; Torres G; González FJ; Alvarado JA
    Arch Inst Cardiol Mex; 1986; 56(1):13-24. PubMed ID: 2943240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.